Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Lars Aabakken. (2015) Scandinavian journal of gastroenterology – the editors-in-chief. Scandinavian Journal of Gastroenterology 50:6, pages 630-635.
Read now
Read now
IM Modlin, M Kidd, I Drozdov, Z-L Siddique & BI Gustafsson. (2008) Pharmacotherapy of neuroendocrine cancers. Expert Opinion on Pharmacotherapy 9:15, pages 2617-2626.
Read now
Read now
M. B. Jacobsen, L. E. Hanssen, F. Kolmannskog, E. Schrumpf, M. H. Vatn & A. Bergan. (1995) Interferon-α2b, with or without Prior Hepatic Artery Embolization: Clinical Response and Survival in Mid-Gut Carcinoid Patients: The Norwegian Carcinoid Study. Scandinavian Journal of Gastroenterology 30:8, pages 789-796.
Read now
Read now
Bo Wängberg, Kjell Geterud, Ola Nilsson, Svante Jansson, Annica Dahlström, Ulf Tylén & Håkan Ahlman. (1993) Embolisation Therapy in the Midgut Carcinoid Syndrome: Just Tumour Ischaemia?. Acta Oncologica 32:2, pages 251-256.
Read now
Read now
J. E. Grønbech, O. Søreide & A. Bergan. (1992) The Role of Resective Surgery in the Treatment of the Carcinoid Syndrome. Scandinavian Journal of Gastroenterology 27:6, pages 433-437.
Read now
Read now
L. E. Hanssen, E. Schrumpf, M. B. Jacobsen, A. N. Kolbenstvedt, F. Kolmannskog, A. Bergan & L. Ø. Dolva. (1991) Extended Experience with Recombinant a-2b Interferon with OR Without Hepatic Artery Embolization in the Treatment OF Midgut Carcinoid Tumours A preliminary report. Acta Oncologica 30:4, pages 523-527.
Read now
Read now
F. Kolmannskog, A. N. Kolbenstvedt, E. Schrumpf & L. E. Hanssen. (1991) Side Effects and Complications after Hepatic Artery Embolization in the Carcinoid Syndrome. Scandinavian Journal of Gastroenterology 26:5, pages 557-562.
Read now
Read now
C. B. H. W. Lamers. (1990) Concluding Remarks Interferon Therapy of Diseases of the Liver and Gastrointestinal Tract. Scandinavian Journal of Gastroenterology 25:sup178, pages 119-121.
Read now
Read now
Articles from other publishers (36)
Erica S. Alexander & Etay Ziv. (2023) Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease. Cancers 15:8, pages 2249.
Crossref
Crossref
Larouche, Akirov, Alshehri & Ezzat. (2019) Management of Small Bowel Neuroendocrine Tumors. Cancers 11:9, pages 1395.
Crossref
Crossref
Marinos Pericleous, Martyn E Caplin, Emmanuel Tsochatzis, Dominic Yu, Luke Morgan-Rowe & Christos Toumpanakis. (2016) Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes. Asia-Pacific Journal of Clinical Oncology 12:1, pages 61-69.
Crossref
Crossref
Kjell Öberg. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1833
1853
.
Kjell Öberg. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
2615
2627.e3
.
Michela Del Prete, Francesco Fiore, Roberta Modica, Vincenzo Marotta, Francesca Marciello, Valeria Ramundo, Antonella Di Sarno, Annachiara Carratù, Chiara de Luca di Roseto, Salvatore Tafuto, Fabiana Tatangelo, Robero Baldelli, Annamaria Colao & Antongiulio Faggiano. (2014) Hepatic arterial embolization in patients with neuroendocrine tumors. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
Crossref
Kjell Öberg. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1809
1828
.
Barbro Eriksson & Kjell Öberg. 2010. Endocrinology. Endocrinology
2774
2786
.
David A. Peterson, James P. Dolan & Jeffrey A. Norton. 2008. Surgery. Surgery
1249
1284
.
Chandrajit P. Raut, Matthew H. Kulke, Jonathan N. Glickman, Richard S. Swanson & Stanley W. Ashley. (2006) Carcinoid Tumors. Current Problems in Surgery 43:6, pages 391-450.
Crossref
Crossref
Irvin M. Modlin, Igor Latich, Mark Kidd, Michelle Zikusoka & Geeta Eick. (2006) Therapeutic Options for Gastrointestinal Carcinoids. Clinical Gastroenterology and Hepatology 4:5, pages 526-547.
Crossref
Crossref
Willscott E. Naugler & Gordon C. Hunt. 2006. Endoscopic Oncology. Endoscopic Oncology
161
172
.
Tahir Shah & Martyn Caplin. (2005) Biotherapy for metastatic endocrine tumours. Best Practice & Research Clinical Gastroenterology 19:4, pages 617-636.
Crossref
Crossref
Gregory A. Kaltsas, G. Michael Besser & Ashley B. Grossman. (2004) The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. Endocrine Reviews 25:3, pages 458-511.
Crossref
Crossref
Irvin Modlin, Kevin Lye & Mark Kidd. 2003. Endocrine Surgery. Endocrine Surgery.
James P. Dolan & Jeffrey A. Norton. 2003. Essential Practice of Surgery. Essential Practice of Surgery
401
415
.
James P. Dolan & Jeffrey A. Norton. 2001. Surgery. Surgery
919
953
.
H. Ahlman, R. Arnold, H. D. Becker, J. Beyer, O. Kisker, G. Klöppel, K. J. Klose, U. Pies, H. D. Röher, R. Rothmund, S. Schneider, B. Simon, D. Simon, B. Stinner, M. Rothmund & R. K. Teichmann. 2000. Praxis der Viszeralchirurgie. Praxis der Viszeralchirurgie
445
553
.
B. Eriksson & K. Öberg. 1998. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
766
789
.
Jonathan D. Harrison & John W. L. Fielding. 1998. Cancer: How Worthwhile is Non-Curative Treatment?. Cancer: How Worthwhile is Non-Curative Treatment?
3
24
.
Paul C. Neary, Paul H. Redmond, Timothy Houghton, Gordon R. K. Watson & David Bouchier-Hayes. (1997) Carcinoid disease. Diseases of the Colon & Rectum 40:3, pages 349-362.
Crossref
Crossref
K. Öberg. 1997. Interferons. Interferons
36
46
.
K. Öberg. (1996) Neuroendocrine gastrointestinal tumours. Annals of Oncology 7:5, pages 453-463.
Crossref
Crossref
S. Faiss, H. Scherübl, E. O. Riecken & B. Wiedenmann. 1996. New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors. New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors
193
207
.
B. Eriksson & K. Öberg. 1995. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
643
665
.
Kjell Öberg. (1994) Treatment of neuroendocrine tumors. Cancer Treatment Reviews 20:4, pages 331-355.
Crossref
Crossref
KJELL ÖBERG, BARBRO ERIKSSON & EVA TIENSUU JANSON. (1994) The Clinical Use of Interferons in the Management of Neuroendocrine Gastroenteropancreatic Tumors. Annals of the New York Academy of Sciences 733:1 Molecular and, pages 471-478.
Crossref
Crossref
B. MARK EVERS, JIN ISHIZUKA, COURTNEY M. TOWNSEND & JAMES C. THOMPSON. (1994) The Human Carcinoid Cell Line, BON.. Annals of the New York Academy of Sciences 733:1 Molecular and, pages 393-406.
Crossref
Crossref
Kjell Öberg. (1993) The Use of Chemotherapy in the Management of Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 22:4, pages 941-952.
Crossref
Crossref
Marc D. Basson, Håkan Ahlman, Bo Wangberg & Irvin M. Modlin. (1993) Biology and management of the midgut carcinoid. The American Journal of Surgery 165:2, pages 288-297.
Crossref
Crossref
I.S. Benjamin. 1993. Surgical Endocrinology. Surgical Endocrinology
538
547
.
B. Eriksson & K. Öberg. 1993. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
299
315
.
K. Öberg. 1993. Molecular Oncology and Clinical Applications. Molecular Oncology and Clinical Applications
363
374
.
Erik Hippe, Viggo Jønsson, Hans von der Maase, Jens Christian Mathiesen & Hans Skovgaard Poulsen. (1991) Homoeostatic response criteria for cancer therapy. European Journal of Cancer and Clinical Oncology 27:12, pages 1715-1716.
Crossref
Crossref
J. FUNK, T. LANGELAND, E. SCHRUMPF & L.E. HANSSEN. (1991) Psoriasis induced by interferon-α. British Journal of Dermatology 125:5, pages 463-465.
Crossref
Crossref
Ph. Rougier, J. Oliveira, M. Ducreux, C. Theodore, J. Kac & J.P. Droz. (1991) Metastatic carcinoid and islet cell tumours of the pancreas: A phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin. European Journal of Cancer and Clinical Oncology 27:11, pages 1380-1382.
Crossref
Crossref